i2e Consulting has been included as a Major Contender in the Life Sciences (DS) Specialist Peak Assessment, 2024 by the Everest Group. This inaugural report includes evaluation across Market Impact (market adoption, portfolio mix, and value delivered) and Vision and Capability (Strategy, scope of services, innovation, delivery footprint) and evaluates 15+ providers’ offerings in life sciences.
Everest Group’s PEAK Matrix® is a proprietary framework used for evaluating service and technology providers. The dimensions of the matrix include measuring impact created in the market and assessment of vision and capability based on the ability to deliver products successfully.
i2e has stood out for its domain specific analytics and technology solutions across the entire life sciences value chain. Other strengths highlighted in the report include i2e’s ability to deliver innovative solutions across emerging technologies, domain expertise complimented by strategic technology partnerships, which helps businesses to unlock value faster.
The recognition underscores i2e’s commitment to lead digital transformation for the life sciences industry through continuous innovation. Our focus on AI innovation and analytics transformation is enabling us to drive real-value transformation at scale for our clients.
i2e leads transformation for the life sciences industry through best-in-class analytics and technology solutions. Our market leading execution capabilities and domain expertise help pharmaceutical companies, biotech, and healthcare organizations deliver innovations that create a healthier world.
We help R&D, clinical development, commercialization functions accelerate time-to-value, prioritize industry leading innovation, and establish portfolio leadership.
